These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 25080504)

  • 1. LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity.
    Gómez-Suaga P; Rivero-Ríos P; Fdez E; Blanca Ramírez M; Ferrer I; Aiastui A; López De Munain A; Hilfiker S
    Hum Mol Genet; 2014 Dec; 23(25):6779-96. PubMed ID: 25080504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A.
    Rivero-Ríos P; Romo-Lozano M; Madero-Pérez J; Thomas AP; Biosa A; Greggio E; Hilfiker S
    J Biol Chem; 2019 Mar; 294(13):4738-4758. PubMed ID: 30709905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease.
    Rivero-Ríos P; Gómez-Suaga P; Fernández B; Madero-Pérez J; Schwab AJ; Ebert AD; Hilfiker S
    Biochem Soc Trans; 2015 Jun; 43(3):390-5. PubMed ID: 26009181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 transport is regulated by its novel interacting partner Rab32.
    Waschbüsch D; Michels H; Strassheim S; Ossendorf E; Kessler D; Gloeckner CJ; Barnekow A
    PLoS One; 2014; 9(10):e111632. PubMed ID: 25360523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRK1 phosphorylation of Rab7 at S72 links trafficking of EGFR-containing endosomes to its effector RILP.
    Hanafusa H; Yagi T; Ikeda H; Hisamoto N; Nishioka T; Kaibuchi K; Shirakabe K; Matsumoto K
    J Cell Sci; 2019 Jun; 132(11):. PubMed ID: 31085713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations.
    Rivero-Ríos P; Romo-Lozano M; Fernández B; Fdez E; Hilfiker S
    Cells; 2020 Jul; 9(7):. PubMed ID: 32709066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.
    Esteves AR; G-Fernandes M; Santos D; Januário C; Cardoso SM
    Mol Neurobiol; 2015 Dec; 52(3):1804-1820. PubMed ID: 25394383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An early endosome regulator, Rab5b, is an LRRK2 kinase substrate.
    Yun HJ; Kim H; Ga I; Oh H; Ho DH; Kim J; Seo H; Son I; Seol W
    J Biochem; 2015 Jun; 157(6):485-95. PubMed ID: 25605758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights into the neurobiology underlying LRRK2-linked Parkinson's disease.
    Gómez-Suaga P; Fdez E; Fernández B; Martínez-Salvador M; Blanca Ramírez M; Madero-Pérez J; Rivero-Ríos P; Fuentes JM; Hilfiker S
    Neuropharmacology; 2014 Oct; 85():45-56. PubMed ID: 24863040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.
    Li X; Tan YC; Poulose S; Olanow CW; Huang XY; Yue Z
    J Neurochem; 2007 Oct; 103(1):238-47. PubMed ID: 17623048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning.
    Dodson MW; Zhang T; Jiang C; Chen S; Guo M
    Hum Mol Genet; 2012 Mar; 21(6):1350-63. PubMed ID: 22171073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
    Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 and Rab GTPases.
    Pfeffer SR
    Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes.
    Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Romo Lozano M; Rivero-Ríos P; Hilfiker S
    Biochem Soc Trans; 2017 Feb; 45(1):147-154. PubMed ID: 28202668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late endosomal traffic of the epidermal growth factor receptor ensures spatial and temporal fidelity of mitogen-activated protein kinase signaling.
    Taub N; Teis D; Ebner HL; Hess MW; Huber LA
    Mol Biol Cell; 2007 Dec; 18(12):4698-710. PubMed ID: 17881733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function.
    Blanca Ramírez M; Madero-Perez J; Rivero-Rios P; Martinez-Salvador M; Lara Ordonez AJ; Fernandez B; Fdez E; Hilfiker S
    Curr Protein Pept Sci; 2017; 18(7):677-686. PubMed ID: 26965688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rab4 affects both recycling and degradative endosomal trafficking.
    McCaffrey MW; Bielli A; Cantalupo G; Mora S; Roberti V; Santillo M; Drummond F; Bucci C
    FEBS Lett; 2001 Apr; 495(1-2):21-30. PubMed ID: 11322941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts.
    Kuwahara T; Inoue K; D'Agati VD; Fujimoto T; Eguchi T; Saha S; Wolozin B; Iwatsubo T; Abeliovich A
    Sci Rep; 2016 Jul; 6():29945. PubMed ID: 27424887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 in Parkinson's disease: protein domains and functional insights.
    Mata IF; Wedemeyer WJ; Farrer MJ; Taylor JP; Gallo KA
    Trends Neurosci; 2006 May; 29(5):286-93. PubMed ID: 16616379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.